Cerevance Inc

  • BioTech/Drugs
  • Boston MA
  • 1 employee
  • Pharmaceuticals
Get Full Info

Company Overview

Website
cerevance.com
Employees
1
Founded in
2016
Industry
BioTech/Drugs
SIC Code
2834 - Pharmaceutical Preparations
More Details

Financials & Stats

Revenue

$50B

More Financials

Recent News & Media

A First-in-Human Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3-Mediated Neuroinflammation (P8-3.016)

  • Apr 8, 2025
  • pubmed.ncbi.nlm.nih.gov

Cerevance Presents Positive Results from Phase 1 Study of

  • Apr 8, 2025
  • globenewswire.com

Solengepras (CVN424): A Novel GPR6 Inhibitor in Clinical Development as an Investigational Therapy for Parkinson’s Disease (P11-5.017)

  • Apr 7, 2025
  • neurology.org

Cerevance Presents Topline Results from Phase 2 ASCEND

  • Apr 1, 2025
  • globenewswire.com

Disruptive Psychopharmacology

  • Nov 19, 2024
  • pmc.ncbi.nlm.nih.gov

Cerevance describes new CD38 inhibitors

  • Dec 22, 2023
  • bioworld.com

Who is Cerevance Inc

Cerevance Inc. is a privately held company headquartered in Boston, Massachusetts. The company is a small business with one employee. Cerevance focuses on the development of novel therapies for neurological disorders. Their research efforts concentrate on treating diseases like Alzheimer's disease. Cerevance distinguishes itself through its commitment to developing treatments that target specific pathways involved in neurodegeneration. They utilize a comprehensive approach, combining cutting-edge research with clinical expertise to advance promising therapies to patients. For more information about Cerevance Inc. and their innovative work, visit their website at cerevance.com.

Company Leadership

Craig Thompson

Chief Executive Officer

Phone Email
Mark Carlton

CSO & Co-Founder

Phone Email
Craig Thompson

Chief Executive Officer

Phone Email
Lee Dawson

SVP, Neuroscience

Phone Email
Mark Copland

Head of IT and Informatics

Phone Email

Companies Similar to Cerevance Inc

Analyze industry trends and opportunities by examining competitors and companies comparable to Cerevance Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
50M Waltham, MA
50M 105 Durham, NC
50M 32 Dallas, TX
50M 49 New York, NY
50M 33 Chattanooga, TN
View More Companies

FAQ

What is the location of Cerevance Inc's headquarters?
The headquarters of Cerevance Inc are situated at One Marina Park Drive, Suite 1410Park, Boston MA
What is Cerevance Inc's official website?
The official website of Cerevance Inc can be found at cerevance.com.
What is Cerevance Inc's current revenue?
As of April 2024, Cerevance Inc's annual revenue reached $50B.
How many employees does Cerevance Inc currently have?
Cerevance Inc employs 1 person as of April 2024
Which industries is Cerevance Inc primarily operating in?
Cerevance Inc operates in the following industries: Pharmaceutical, Biotechnology, Therapeutics
Who is the Chief Executive Officer of Cerevance Inc?
Cerevance Inc's Chief Executive Officer is Craig Thompson
When was Cerevance Inc founded?
Cerevance Inc was founded in 2016.

Employee Directory

Key Employees

Brad Margus

Co-Founder

Phone Email

Steve Sheardown

Head of Molecular Biology and Cell Engineering

Phone Email

Kim Matthews

Senior Director, Head of DMPK, Cerevance

Phone Email